AbbVie Other Non-Current Liabilities 2010-2024 | ABBV

AbbVie other non-current liabilities for the quarter ending December 31, 2024 were $30.129B, a 6.8% decline year-over-year.

  • AbbVie other non-current liabilities for 2024 were $30.129B, a 6.8% decline from 2023.
  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.

AbbVie Other Non-Current Liabilities 2010-2024 | ABBV

  • AbbVie other non-current liabilities for 2024 were $30.129B, a 6.8% decline from 2023.
  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B